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1. Introduction 
Magnetic Resonance Imaging (MRI) is a medical imaging technique that has been in clinical 
use since the 1980’s, and has advanced significantly in the last decade.  
MRI scans are usually performed at magnetic field strengths of 1.5 to 3.0 Tesla. Such a 
magnetic field is at least 25,000 times stronger than that of the earth and is required to align 
and modify the behaviour of unevenly charged protons in the patient’s body. Brief radio 
frequency pulses with specific properties are applied, which change the axis of rotation 
(precession) in the protons. The protons rapidly resume their original precession angle and 
emit a small signal, which is used to compute images. Importantly, the behaviour of 
resuming their previous state is strongly dependent on the molecular environment; in other 
words: different tissue composition creates different image contrasts (14-16) 
The main advantages of MRI techniques include their completely non-invasive nature, lack 
of any harmful radiation or radioactivity, and the lack of need for Iodine-based contrast 
agents. It is considered to be free of any harm to patients, but – since metal is affected in a 
magnetic field – it may not be performed if the patient carries certain magnetic material such 
as specific electronic devices or some metallic implants. The most commonly performed 
MRI scans are of the head, brain, spine, large joints and abdomen (15). 
Cardiac applications of MRI have been applied since the late 1980’s and have evolved into a 
robust, clinically valid application due to recent advances in both hardware and software. 
CMR provides a variety of valuable diagnostic information including anatomy and function 
of the heart, flow of blood, and perfusion and viability of the myocardium. Its most unique 
advantage is the ability to visualize tissue characteristics selectively based on molecular 
environments, adding a new and valuable piece of information to medical testing 
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Contrast-enhanced cardiac magnetic resonance imaging (CMR) allows for a non-invasive 
assessment of the tissue composition using contrast-free (T2, e.g. STIR) and contrast-
enhanced techniques (early and late Gadolinium enhancement). Together with a functional 
assessment, it can be used to determine the acuity of e.g. inflammatory diseases and provide 
a non-invasive follow-up tool.  
1.1 CMR techniques used 
Functional imaging with high-resolution sequences such as SSFP cines allow to assess the 
whole left and right ventricles and calculate volumes, ejection fraction and mass. Myocardial 
wall stress can be calculated from these. 
Assessment of valvular function is needed and may require additional flow studies for the 
calculation of regurgitation fraction of aortic and mitral valve. Assessment of the 
pericardium can be done on the functional images, too. 
T2-weighted images with fat suppression allow assessing myocardial water content, thus 
allowing to assess the stage of disease. To provide an “internal standard”, skeletal muscle is 
used as control; an SI-ratio of more than 2.0 is considered abnormal. 
T1-weighted images allow to demonstrate acute inflammatory changes including increased 
extracellular volume and membrane integrity. As in T2-weighted imaging a skeletal muscle 
is used as “internal standard”; an enhancement – ratio (myocardial enhancement / muscle 
enhancement) of more than 4.0 is considered abnormal. The body-coil is used to obtain 
homogenous SI through the images, short axis or axial images are selected to optimize 
image quality. 
Newer sequences may improve image quality and allow for the use of multi-element 
coils. 
Late Gadolinium enhancement allows to non-invasively diagnose irreversible damage in the 
myocardium (e.g. fibrosis, infarcts). Due to the specific location in ischemic damages (starts 
at the subendocardial layer), it is easy to distinguish non-ischemic damages (as in 
myocarditis) from ischemic problems. Combining T2-information, early and late 
enhancement, CMR is able to safely assess the acuity and reversibility of the disease process 
in non-ischemic Cardiomyopathies and inflammatory processes (16). 
2. Left ventricular non-compaction 
2.1 Introduction 
Left ventricular non-compaction (LVNC) is a distinct cardiomyopathy resulting from arrest of 
fetal development of the heart (1). This leads to altered myocardial architecture that is seen as a 
two layered myocardium with a thin, compacted epicardial layer and a thick, non-compacted 
endocardial region. The non-compacted myocardial region is comprised of prominent 
trabeculations and deep intertrabecular recesses that directly communicate with the left 
ventricular cavity (2, 3) .The condition may present without any associated cardiac 
malformation and is then labelled isolated left ventricular non compaction (LVNC). Non 
compacted myocardium is also seen in conjunction with other cardiac abnormalities including 
cyanotic congenital heart disease, Ebstein’s anomaly and other cardiomyopathies. Clinical 
presentation in LVNC is seen with congestive heart failure, ventricular arrhythmia and 
systemic thromboembolism.  The condition is listed as an unclassified cardiomyopathy in the 
WHO and European Society of Cardiology classification of cardiomyopathies (4, 5) and as a 
primary genetic cardiomyopathy in the American Heart Association classification (6).  
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Early intrauterine myocardial perfusion is through direct diffusion of nutrients from the 
left ventricular (LV) cavity to the myocardium. The presence of deep trabecular recesses 
filled with blood facilitates this process. Development of coronary circulation in the 
second trimester provides direct blood supply to the myocardium with consequent 
compaction of extensive intrauterine trabeculations of the myocardial wall. Failure in this 
process results in a non-compacted myocardium (1). The exact mechanism for this is not 
known. 
2.3 Inheritance 
Both sporadic and familial forms are described. In the latter an autosomal dominant or X-
linked inheritance with genetic heterogeneity is reported.  Mutations in MYH7 encoding β-
myosin heavy chain is seen in patients with Ebstein’s anomaly and LVNC (7). In X-linked 
inheritance mutation of G4.5 TAZ gene with abnormality of tafazzin is reported (8, 9). This 
can be seen with or without Barth syndrome. 
2.4 Prevalence 
The presence of significant non compaction is estimated at 1:2.000 in the general population 
(10). The condition is, however, more prevalent in heart failure patients. More frequent use 
of cardiac imaging in clinical practice has increased recognition of this condition. 
2.5 Clinical presentation 
This is variable from asymptomatic individuals to those with severe disease presenting with 
heart failure, ventricular arrhythmia and systemic thromboembolism (9, 11-13). Non cardiac 
features may include facial dysmorphism and neuromuscular disorders. 
2.6 Diagnostic criteria 
Trabeculation in the LV wall is seen even in healthy volunteers. To separate benign LV 
trabeculation from pathological LVNC following diagnostic criteria is proposed. 
- Echo: ratio of non-compacted to compacted myocardium in end-systole of > 2:1 (14) 
- Cardiac MRI: ratio of non-compacted to compacted myocardium in end-diastole of > 
2.3:1 (15) 
2.7 Cardiac MRI in the diagnosis of LVNC 
Cardiovascular imaging is central to the diagnosis of left ventricular non compaction. 
Compared to echocardiography better resolution of cardiac MRI makes it a preferred 
imaging modality particularly in those with limited echo windows.  Additionally, non-
compacted segment may be confined to the LV apex where echo has inherent imaging 
problems.  Cardiac MRI is also reliable in distinguishing LVNC from other causes of LV 
apical deformity including apical variant of hypertrophic cardiomyopathy, endomyocardial 
fibrosis and apical thrombus. 
2.8 Cardiac MRI imaging protocol 
LV morphology and function is evaluated with cine images using a steady-state free 
precession (SSFP) technique. Images are usually displayed in three to six long axes and in 
contiguous short axis projections.  
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After baseline imaging post Gadolinium delayed enhancement (LGE) is performed to assess 
myocardial fibrosis. 
2.9 Myocardial morphology on cardiac MRI 
Besides pathological LVNC myocardial trabeculation is also seen in normal healthy 
individuals as well as in patients with hypertrophic and dilated cardiomyopathies. In LVNC 
distribution of non-compacted myocardium can be accurately assessed by MRI. There is 
involvement of the LV apex along with more frequent non compaction of the mid and apical 
segments of inferior and lateral wall. Non-compaction of the right ventricular wall is seen in 
some of these individuals. However, it is the severity of non-compaction rather than the 
distribution that distinguishes pathological LVNC from other disorders (15).  A ratio of non-
compacted to compacted myocardium of > 2.3 in diastole has as a sensitivity of 86% with a 
very high specificity of 99% and positive and negative predictive values of 75% and 99% 
respectively. 
 In contrast to echocardiography where systolic frame images are used to measure the 
relationship of non-compacted to compacted myocardium, diastolic frame images are used 
in MRI. This is possible because of improved spatial resolution of MRI. In systole, thickening 
of compacted myocardium may account for the altered relationship of compacted and non-
compacted myocardium and this may explain the lower ratio of non-compacted to 
compacted myocardium of > 2:1 used in echocardiography (15). 
Others have suggested that a trabeculated LV mass of > 20% of the total LV mass separates 
LVNC from other causes of LV trabeculation both benign and that seen in dilated and 
hypertrophic cardiomyopathy  with a sensitivity and specificity of > 90%(16). 
2.10 Myocardial kinetics and function 
Cine short-axis images are used for calculation of ejection fraction (EF) using Simpson’s 
method by tracing end diastolic and end systolic volumes in all imaging planes. 
The spectrum of myocardial function may range from normal to severe systolic dysfunction. 
Quantitative assessment of left ventricular function by cardiac MRI is the current reference 
standard and can be compared longitudinally. However, in patients with LVNC 
interobserver and intraobserver reproducibility may be affected, depending on whether the 
inner contour (interface between the LV cavity and non-compacted myocardium) or outer 
contour (interface between the compacted and non-compacted myocardium) are used to 
calculate LV volumes. Latter may have the effect of increasing left ventricular end-diastolic 
volume and falsely overestimating volumetric EF (17).  Therefore, additional qualitative 
information of LV function from review of myocardial kinetics on cine images is suggested.  
2.11 Tissue characterization-late gadolinium enhancement 
Late Gadolinium enhancement (LGE), a marker of myocardial fibrosis, was seen in 23 out of 42 
patients (55%) in a study conducted by Nucifora, et al. The degree of LGE in their study 
correlated with clinical symptoms, LV systolic dysfunction and arrhythmia (18). In another 
study Dodd et al. demonstrated a correlation between trabecular LGE and LV dysfunction (19).  
2.12 Clinical management 
This is largely supportive with standard heart failure therapy. Heart transplantation 
remains an option in patients with advanced disease. Ventricular arrhythmia is not directly 
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related to severity of LV dysfunction and a prophylactic ICD is recommended. 
Anticoagulation to prevent thromboembolic complications is recommended, particularly in 
patients with severe contractile dysfunction. Family members of affected individual should 
be screened and counseled. 
2.13 Summary 
Left ventricular non-compaction is a rare cardiomyopathy arising from developmental 
arrest of the left ventricular myocardium. It has distinct morphometric appearance with a 
two layer myocardium-a compacted and a non-compacted zone. Sporadic and familial 
forms are described. The triad of heart failure, arrhythmia and systemic thromboembolism 
are feared complications. In milder forms the patient may be completely asymptomatic. 
Increased awareness of this disorder and improvement in cardiovascular imaging has 
contributed to greater recognition of this condition. Cardiac MRI with its improved spatial 
resolution can conclusively establish the diagnosis and the unique property of LGE on 
cardiac MRI can identify severe forms of this disorder which may have both therapeutic and 
prognostic implications. 
3. Stress-induced or “Tako-Tsubo” cardiomyopathy 
3.1 Introduction 
This cardiomyopathy is a transient and reversible cardiomyopathy that was first reported in 
Japan by Dote, et al., in 1991 (1). Clinical presentation may be indistinguishable from acute 
coronary syndrome, invariably necessitating coronary angiography for exclusion of 
obstructive coronary artery disease. Prevalence is in 1-2% of patients undergoing coronary 
angiography for acute coronary syndrome.  Complimentary imaging modalities including 
echocardiography and cardiac MRI are helpful in diagnosis and in monitoring clinical 
recovery. Absence of delayed hyperenhancement on cardiac MRI is particularly important 
in differentiating this condition from ischemic and other types of non-ischemic 
cardiomyopathy and acute myocarditis (2). Based on morphologic features of the left 
ventricle, presumed causative role of stress and catecholamine excess and transient nature of 
the contractile dysfunction, other nomenclature used to describe this cardiomyopathy 
include ampulla cardiomyopathy, stress cardiomyopathy or catecholamine cardiotoxicity 
and transient left ventricular apical ballooning syndrome. 
3.2 Pathophysiology 
Distinct pattern of contractile abnormality is noted in the left ventricle.  In the typical case 
the LV apex is dyskinetic and expanded and may be associated with hyperdynamic 
contractility of the basal LV segments. The shape of left ventricle in systole resembles a 
Japanese octopus trap (Takotusbo), which has a narrow neck and a wide base (1).  
The condition is associated with markedly elevated circulating catecholamine, which is 
assumed to be central in the pathophysiology of this condition though exact mechanism at 
the cellular level is not fully understood. In a report by Wittstein, et al., two to three times 
higher plasma catecholamine concentrations were found in 13 patients with transient LV 
apical ballooning syndrome compared with 7 controls hospitalized for acute MI with Killip 
class III heart failure (3). Other proposed mechanisms include neurogenic stunned 
myocardium, coronary vasospasm, microvasculature dysfunction and altered cellular 
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metabolism (4, 8-11). Preponderance of females afflicted by this condition is unclear. 
Estrogen deficiency in the post-menopausal state may play a role. Of particular interest, in 
other conditions with elevated catecholamine levels like subarachnoid hemorrhage, 
segmental wall motion abnormality is also predominantly seen in women (12). A reverse 
pattern of contractile abnormality with apical sparing has also been reported (13).  
3.3 Clinical features 
The presentation is typically following intense emotional or physical stress. The 
condition is predominantly seen in post-menopausal female with more than 80% of 
patients being female and more than 90% above the age of 50 years.  Presentation may be 
clinically indistinguishable from ACS including ST segment elevation on ECG and rise in 
cardiac biomarkers. Chest pain and mild dyspnea are most common features 
encountered in more than 70% of patients. More significant heart failure and some 
degree of LVOT tract obstruction from hyperdynamic contraction of basal LV segments 
may be encountered in 15-20% of patients. Complications including cardiogenic shock 
may complicate the clinical course in up to 5% of patients. This may be secondary to 
either severe LV systolic dysfunction or obstruction of LVOT or both. Systemic 
thromboembolism from apical LV thrombus is reported. Ventricular arrhythmia is seen 
in 1-2% of patients (1-14).   
Although presentation is typically encountered in the setting of profound emotional or 
physical stress, this characteristic trigger can be absent in up to a third of patients (14). Right 
ventricular involvement in takotsubo is seen in 25-30% of patients and is associated with a 
more complicated clinical course (15). It is encountered in patients with more severe LV 
involvement (16). However, isolated right ventricular takotsubo has been reported (17). 
3.4 Diagnosis 
History of intense emotional or physical stress and a typical pattern of left ventricular 
contractile dysfunction on cardiac imaging are suggestive of the diagnosis. Invariably, 
however, coronary angiography is required in the acute setting to exclude obstructive 
coronary artery disease. Both echocardiography and cardiac MRI provide information on 
the distinct morphologic and contractile dysfunction of takotsubo cardiomyopathy.  
However, cardiac MRI is instrumental in conclusively distinguishing takotsubo 
cardiomyopathy from other conditions. 
3.5 Cardiac MRI in the diagnosis of Takotsubo cardiomyopathy 
3.5.1 Assessment of myocardial morphology and contractility 
Imaging sequence includes Standard TrueFISP (fast imaging with steady-state precession) 
cine images acquisition in 3 long-axis slices and 11 to 15 short-axis slices, 7 mm in thickness 
with a 3-mm interslice gap, achieving full ventricular coverage. Apical ballooning with or 
without mid myocardial contractile dysfunction and with basal sparing can be easily 
appreciated. In addition hyperdynamic contraction of basal segments with LVOT 
obstruction can be identified.  The above-described pattern of contractile dysfunction in 
takotsubo cardiomyopathy does not fit a coronary artery distribution and is helpful in 
differentiating this condition from acute coronary syndrome. Left ventricular apical 
thrombus, which can complicate the clinical course, can be diagnosed using the long axis 
cine projections and LGE images.  
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Right ventricular involvement is seen in some patients. Because of the difficulty in assessing 
RV morphology and function by echocardiography, cardiac MRI is a preferred modality for 
identification of right ventricular involvement (15-17) and in quantification of RV dysfunction. 
However, cautious interpretation of RV dysfunction by MRI is advised in view of some degree 
of projection dependent contractile dysfunction seen even in normal subjects (18-19). 
Sequential cardiac imaging study will show normalization of contractile dysfunction within 







Fig. 1. Long axis and short axis SSFP images in diastole (a: 4-chamber view long axis; b: 2-
chamber view long axis; c: short axis at mid ventricular level) in a patient with genetically 
proven non-compaction cardiomyopathy. Note increased end-diastolic volume and increased  
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3.5.2 First pass myocardial perfusion 
In contrast to apical myocardial infarction rest first-pass contrast enhanced myocardial 
perfusion on cardiac MRI is usually normal in takotsubo cardiomyopathy providing another 







Fig. 2. Set of mulitple long axis SSFP cines in diastole (2-a) and systole (2-b). Note hypo- to 
akinetic mid ventricular and apical segments in this apical ballooning syndrome. 
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3.5.3 Tissue characterization – Myocardial edema on t2-weighted images 
Myocardial edema following myocardial injury, ischemic or non-ischemic, can be detected 
using T2-weighted short tau inversion recovery (T2-STIR) images obtained in basal, mid, and 
apical short-axis, vertical long-axis, 3-chamber, and horizontal long-axis planes (20). 
Elevated T2- signal consistent with myocardial edema is seen in patients with takotsubo 
cardiomyopathy. T2 signal is highest in myocardium with the most impaired function and 
resolves over time (21-22).  Myocardial edema on T2-STIR sequence is also a hallmark of 
ischemic myocardium prior to irreversible myocardial injury (23). In contrast to ischemic 
myocardium, myocardial edema in patients with takotsubo cardiomyopathy may represent 
catecholamine-induced myocardial stunning due to microvascular dysfunction (2).   
 
 
Fig. 3. Short axis SSFP cine image in diastole in a patient with non-compaction 
cardiomyopathy. Line A denotes the thickness of the compacted myocardium, line B 
denotes the non-compacted myocardium. 
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3.5.4 Tissue characterization – Late gadolinium enhancement (LGE) on T1-weighted 
Images 
Gadolinium concentrates in region of damaged myocardium and appears bright on T1-
weighted images (24). Cine images using a segmented gradient-echo sequence (6-mm slice 
thickness) is obtained in multiple short-axis views every 10 mm covering the whole left 
ventricle (LV). Ten to 15 min after injection of a Gadolinium-based contrast agent, images 
are acquired in the same orientation as the cine images using a segmented inversion-
recovery gradient-echo pulse sequence. Abnormal myocardium is usually bright on T1-
weighted images. LGE is absent in patients with takotsubo cardiomyopathy (2, 3, 5, 25). This 
indicates viable myocardium and is particularly useful in distinguishing it from myocardial 
infarction, other types of non-ischemic cardiomyopathy and myocarditis.   
In a prospective study using CMR conducted by Eitel, et al., 6.100 patients presenting with 
ACS underwent coronary angiography and left ventriculography.  In 59 patients with 
normal coronary angiography and typical contractile pattern of takotsubo cardiomyopathy, 
cardiac MRI was performed. Using strict criteria of absence of any late Gadolinium 
enhancement, takotsubo cardiomyopathy was diagnosed in 38.  In the remaining 21 
patients, based on the pattern of delayed hyperenhancement, a diagnosis of ischemic heart 
disease was made in 13 and of myocarditis in 8 patients (2).  However, in a study of 15 
patients with takotsubo cardiomyopathy, low intensity, patchy, mid-myocardial LGE was 
seen in 5 out of 15 patients. Increase in extracellular collagen was reported to be a plausible 
mechanism for this finding (26). 
3.5.5 Coronary magnetic resonance angiography (MRA) 
Coronary MRA though quite helpful in delineating the course of proximal coronary arteries 
(27), is not feasible for assessment of obstructive coronary artery disease and hence cannot 
be substituted for invasive or CT angiography (28). 
3.6 Management 
Treatment is supportive. ß-blockers are the mainstay in blunting catecholamine 
cardiotoxicity. This should be used cautiously to avoid worsening of heart failure. In 
patients with cardiogenic shock inotropic and IABP support may be required. However, the 
possibility of exacerbating LVOT obstruction with these measures requires careful 
monitoring and appropriate adjustment of therapy including discontinuation of inotropes 
and IABP support (29). ACE-I are beneficial and warfarin is recommended till left 
ventricular recovery is complete. In addition to these therapeutic measures, emotional or 
physical precipitating factors should be addressed. Prognosis is usually very good with 
complete or near complete recovery of LV contractile dysfunction. For prevention of rare 
recurrent episodes of takotsubo even after removal of initial trigger, indefinite 
neurohormonal modulation with ß-blockers and ACE-I merits consideration (30).  
3.7 Summary 
Takotsubo cardiomyopathy presents with clinical features that can be indistinguishable 
from acute coronary syndrome. However, distinct myocardial contractile dysfunction on 
echocardiography or cardiac MRI, absence of obstructive CAD on invasive angiography and 
exposure to an emotional or physical stressor is helpful in initially distinguishing it from 
ACS.  Furthermore, cardiac MRI with normal first-pass contrast enhanced rest myocardial 
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perfusion, reversible myocardial edema in regions of contractile dysfunction and absence of 
late gadolinium enhancement is strongly indicative of the diagnosis of takotsubo 
cardiomyopathy. Resolution of contractile dysfunction, days to weeks after initial 
presentation, is confirmatory of the diagnosis. 
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